Efficient Cutoff Points for Three Screening Tests for Detecting Undiagnosed Diabetes and Pre-Diabetes
Open Access
- 1 June 2005
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 28 (6) , 1321-1325
- https://doi.org/10.2337/diacare.28.6.1321
Abstract
OBJECTIVE—Opportunistic screening for undiagnosed type 2 diabetes and pre-diabetes (either impaired glucose tolerance or impaired fasting glucose) is recommended by the American Diabetes Association. The aim of this study was to determine efficient cutoff points for three screening tests for detecting undiagnosed diabetes alone or both undiagnosed diabetes and pre-diabetes. RESEARCH DESIGN AND METHODS— We estimated the number of individuals with undiagnosed diabetes alone or with both undiagnosed diabetes and pre-diabetes that could be detected by using different cutoff points for each screening test as the product of the prevalence of each condition, the sensitivity of the tests at each cutoff point for identifying each condition, and the number of individuals who would be eligible for screening in the U.S. We estimated the total cost of opportunistic screening by multiplying the cost for screening one person by the number of individuals screened. RESULTS—The most efficient cutoff points for both detecting pre-diabetes and undiagnosed diabetes (100 mg/dl for the fasting plasma glucose test, 5.0% for the HbA1c test, and 100 mg/dl for the random capillary blood glucose test) were less than those for detecting undiagnosed diabetes alone (110 mg/dl for the fasting plasma glucose test, 5.7% for the HbA1c test, and 120 mg/dl for the random capillary blood glucose test). CONCLUSIONS—A lower cutoff value should be used when screening for pre-diabetes and undiagnosed diabetes together than when screening for undiagnosed diabetes alone.Keywords
This publication has 14 references indexed in Scilit:
- Screening for Type 2 DiabetesDiabetes Care, 2004
- Costs of Screening for Pre-diabetes Among U.S. AdultsDiabetes Care, 2003
- The Prevention or Delay of Type 2 DiabetesDiabetes Care, 2003
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2003
- Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trialThe Lancet, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Projection of Diabetes Burden Through 2050Diabetes Care, 2001
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose ToleranceNew England Journal of Medicine, 2001
- The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screeningInternational Journal of Obesity, 2000
- A mobile clinic experience: Nurse practitioners providing care to a rural populationJournal of Pediatric Health Care, 1994